Guided Therapeutics Stock Market Value
| GTHP Stock | USD 0.19 0.03 18.75% |
| Symbol | Guided |
Guided Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Guided Therapeutics' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Guided Therapeutics.
| 06/03/2024 |
| 11/30/2024 |
If you would invest 0.00 in Guided Therapeutics on June 3, 2024 and sell it all today you would earn a total of 0.00 from holding Guided Therapeutics or generate 0.0% return on investment in Guided Therapeutics over 180 days. Guided Therapeutics is related to or competes with Nephros, Intelgenx Technologs, and SANUWAVE Health. Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices More
Guided Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Guided Therapeutics' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Guided Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 19.91 | |||
| Information Ratio | 0.1128 | |||
| Maximum Drawdown | 70.0 | |||
| Value At Risk | (20.00) | |||
| Potential Upside | 26.67 |
Guided Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Guided Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Guided Therapeutics' standard deviation. In reality, there are many statistical measures that can use Guided Therapeutics historical prices to predict the future Guided Therapeutics' volatility.| Risk Adjusted Performance | 0.1024 | |||
| Jensen Alpha | 2.03 | |||
| Total Risk Alpha | (0.72) | |||
| Sortino Ratio | 0.0893 | |||
| Treynor Ratio | (2.01) |
Guided Therapeutics Backtested Returns
Guided Therapeutics is out of control given 3 months investment horizon. Guided Therapeutics holds Efficiency (Sharpe) Ratio of 0.11, which attests that the entity had a 0.11% return per unit of risk over the last 3 months. We have analyze and collected data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.69% are justified by taking the suggested risk. Use Guided Therapeutics Market Risk Adjusted Performance of (2.00), risk adjusted performance of 0.1024, and Downside Deviation of 19.91 to evaluate company specific risk that cannot be diversified away. Guided Therapeutics holds a performance score of 8 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of -0.95, which attests to possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Guided Therapeutics are expected to decrease slowly. On the other hand, during market turmoil, Guided Therapeutics is expected to outperform it slightly. Use Guided Therapeutics total risk alpha and the relationship between the potential upside and price action indicator , to analyze future returns on Guided Therapeutics.
Auto-correlation | 0.05 |
Virtually no predictability
Guided Therapeutics has virtually no predictability. Overlapping area represents the amount of predictability between Guided Therapeutics time series from 3rd of June 2024 to 1st of September 2024 and 1st of September 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Guided Therapeutics price movement. The serial correlation of 0.05 indicates that only as little as 5.0% of current Guided Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.05 | |
| Spearman Rank Test | 0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Guided Therapeutics lagged returns against current returns
Autocorrelation, which is Guided Therapeutics otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Guided Therapeutics' otc stock expected returns. We can calculate the autocorrelation of Guided Therapeutics returns to help us make a trade decision. For example, suppose you find that Guided Therapeutics has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Guided Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Guided Therapeutics otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Guided Therapeutics otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Guided Therapeutics otc stock over time.
Current vs Lagged Prices |
| Timeline |
Guided Therapeutics Lagged Returns
When evaluating Guided Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Guided Therapeutics otc stock have on its future price. Guided Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Guided Therapeutics autocorrelation shows the relationship between Guided Therapeutics otc stock current value and its past values and can show if there is a momentum factor associated with investing in Guided Therapeutics.
Regressed Prices |
| Timeline |
Pair Trading with Guided Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Guided Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guided Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Guided OTC Stock
| 0.48 | SEMHF | Siemens Healthineers | PairCorr |
| 0.44 | SMMNY | Siemens Healthineers | PairCorr |
| 0.44 | PHG | Koninklijke Philips | PairCorr |
| 0.42 | SCTSF | Scottie Resources Corp | PairCorr |
The ability to find closely correlated positions to Guided Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Guided Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Guided Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Guided Therapeutics to buy it.
The correlation of Guided Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Guided Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Guided Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Guided Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Guided OTC Stock Analysis
When running Guided Therapeutics' price analysis, check to measure Guided Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guided Therapeutics is operating at the current time. Most of Guided Therapeutics' value examination focuses on studying past and present price action to predict the probability of Guided Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guided Therapeutics' price. Additionally, you may evaluate how the addition of Guided Therapeutics to your portfolios can decrease your overall portfolio volatility.